🇺🇸 FDA
Pipeline program

B007

B007-102

Phase 3 small_molecule active

Quick answer

B007 for Primary Membranous Nephropathy is a Phase 3 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 2 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Primary Membranous Nephropathy
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials